FDA Approves Controversial Neuralink Brain Implants for Human Testing

Neuralink received approval from the U.S. Food and Drug Administration to begin human trials of its brain-computer interface technology.
The company aims to aid people with paralysis and other neurological conditions through implants that can decode brain signals and relay them to computers.
Neuralink's devices require brain surgery to insert tiny electrodes in the brain that can read neural signals and has previously only been tested in animals.
Elon Musk, the CEO of Neuralink, has faced criticism over the invasiveness of the technology and the company's treatment of test animals.
While brain-computer interfaces could help disabled individuals in the future, experts warn widespread use of the technology may be problematic.